What is Creatv Microtech?
Creatv Microtech, founded by Dr. Cha-Mei Tang, is a privately-held entity specializing in microfabrication and biodetection. The company's core competency lies in its advanced research and development, leveraging expertise in high-aspect-ratio microfabrication and ultra-sensitive biodetection. Its proprietary microfabricated CellSieve™ microfilters are particularly noted for their application in liquid cell biopsy for cancer diagnostics, a field where Creatv's fabrication capabilities for micro-metal and composite microstructures are considered world-leading. The company's business model is deeply rooted in scientific and engineering innovation.
How much funding has Creatv Microtech raised?
Creatv Microtech has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Creatv Microtech?
With the recent influx of capital and a major strategic investment, Creatv Microtech is poised for significant expansion. The large-scale, late-stage funding suggests a transition towards commercial scaling and broader market penetration for its specialized microfiltration and biodetection technologies. Future developments are likely to focus on enhancing the production capacity of its CellSieve™ product line and forging strategic partnerships to accelerate the adoption of its cancer diagnostic solutions. This financing will be instrumental in solidifying its market position and driving further innovation in the biotech and diagnostics landscape.
See full Creatv Microtech company page
